RECITALSRegistration Rights Agreement • April 18th, 2003 • Xoma LTD /De/ • Pharmaceutical preparations • Delaware
XOMA Ltd.Underwriting Agreement • September 24th, 2003 • Xoma LTD /De/ • Pharmaceutical preparations • New York
Exhibit 4 [*] indicates that a confidential portion of the text of this agreement has been omitted. The non-public information has been filed separately with the Securities and Exchange Commission. AMENDMENT NO. 1 TO LICENSE AGREEMENT This Amendment...License Agreement • November 30th, 2004 • Xoma LTD /De/ • Pharmaceutical preparations • California
WARRANTWarrant Agreement • August 18th, 1997 • Xoma Corp /De/ • Pharmaceutical preparations • New York
XOMA LTD.Indenture • February 8th, 2005 • Xoma LTD /De/ • Pharmaceutical preparations • New York
Exhibit 5 [*] indicates that a confidential portion of the text of this agreement has been omitted. REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT, dated as of November 26, 2001 (this "Agreement"), is made by and among XOMA Ltd., a...Registration Rights Agreement • December 13th, 2001 • Xoma LTD /De/ • Pharmaceutical preparations • New York
RECITALSSettlement Agreement • March 19th, 1998 • Xoma Corp /De/ • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of August 13, 1997, among XOMA Corporation, a Delaware corporation (the "Company"), Southbrook International Investments, Ltd., a...Registration Rights Agreement • August 18th, 1997 • Xoma Corp /De/ • Pharmaceutical preparations • New York
XOMA CORPORATION, Issuer AND Trustee INDENTURE Dated as of [·], 20[·] Debt SecuritiesIndenture • August 22nd, 2012 • XOMA Corp • Pharmaceutical preparations • New York
Whereas, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
SUPPLY AGREEMENT CHARLES RIVER BIOTECHNICAL SERVICES FOR THE PRODUCTION OF ASCITES FOR XOMA CORPORATIONSupply Agreement • March 19th, 1998 • Xoma Corp /De/ • Pharmaceutical preparations • California
Exhibit 3 [*] indicates that a confidential portion of the text of this agreement has been omitted. INVESTMENT AGREEMENT dated as of November 26, 2001Investment Agreement • December 13th, 2001 • Xoma LTD /De/ • Pharmaceutical preparations • New York
WARRANTWarrant Agreement • June 29th, 1998 • Xoma Corp /De/ • Pharmaceutical preparations • New York
XOMA CORPORATION AND _____________, AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF __________Preferred Stock Warrant Agreement • March 10th, 2021 • XOMA Corp • Pharmaceutical preparations • New York
THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between XOMA CORPORATION, a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
XOMA CORPORATION AND , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [ ], 20Common Stock Warrant Agreement • March 7th, 2018 • XOMA Corp • Pharmaceutical preparations • New York
COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between XOMA CORPORATION, a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 10th, 2009 • Xoma LTD /De/ • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 5, 2009, between XOMA Ltd., a Bermuda company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
MANUFACTURING AGREEMENT AGREEMENT dated as of January 1, 1991 by and between XOMA CORPORATION ("Xoma"), a Delaware corporation with principal offices at 2910 7th Street (P.O. Box 11261), Berkeley, California 94710, and PFIZER INC ("Pfizer"), a...Manufacturing Agreement • March 19th, 1998 • Xoma Corp /De/ • Pharmaceutical preparations • California
XOMA CORPORATION AND _____________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF __________Warrant Agreement • March 10th, 2021 • XOMA Corp • Pharmaceutical preparations • New York
THIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [•], between XOMA CORPORATION, a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
BACKGROUNDLicense Agreement • March 14th, 2003 • Xoma LTD /De/ • Pharmaceutical preparations • New York
Exhibit 10.19 STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE - NET AMERICAN INDUSTRIAL REAL ESTATE ASSOCIATION 1. Basic Provisions ("Basic Provisions") 1.1 Parties: This Lease ("Lease"), dated for reference purposes only November 2, 2001, is made...Lease Agreement • April 1st, 2002 • Xoma LTD /De/ • Pharmaceutical preparations
ASSUMPTION AGREEMENT INTERNATIONAL GENETIC ENGINEERING, INC. 1985 NONQUALIFIED STOCK OPTION PLAN This Agreement is made as of November 13, 1989, by an between XOMA Corporation, a Delaware Corporation ("XOMA") and (blank) ("Employee"). WHEREAS: 1....Assumption Agreement • March 19th, 1998 • Xoma Corp /De/ • Pharmaceutical preparations
LICENSE AGREEMENTLicense Agreement • November 30th, 2004 • Xoma LTD /De/ • Pharmaceutical preparations • New York
XOMA CORPORATION SALES AGREEMENTSales Agreement • November 12th, 2015 • XOMA Corp • Pharmaceutical preparations • New York
XOMA Corporation, a Delaware corporation, (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
AGREEMENTCollaboration Agreement • March 19th, 1998 • Xoma Corp /De/ • Pharmaceutical preparations • New York
42,000,000 Units XOMA LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • February 2nd, 2010 • Xoma LTD /De/ • Pharmaceutical preparations • New York
XOMA CORPORATION Depositary Shares Each Representing 1/1000th of a Share of At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • August 5th, 2021 • XOMA Corp • Pharmaceutical preparations • New York
XOMA LTD., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20__ SENIOR DEBT SECURITIESIndenture • February 11th, 2011 • Xoma LTD /De/ • Pharmaceutical preparations • New York
WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • December 13th, 2013 • XOMA Corp • Pharmaceutical preparations • New York
RECITALSSecurity Agreement • April 18th, 2003 • Xoma LTD /De/ • Pharmaceutical preparations • California
XOMA CORPORATION AND _____________, AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF __________Warrant Agreement • March 10th, 2021 • XOMA Corp • Pharmaceutical preparations • New York
THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between XOMA CORPORATION, a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
Exhibit 2 [*] indicates that a confidential portion of the text of this agreement has been omitted. DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • December 13th, 2001 • Xoma LTD /De/ • Pharmaceutical preparations • New York
XOMA CORPORATION AND , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [ ], 20Debt Securities Warrant Agreement • March 7th, 2018 • XOMA Corp • Pharmaceutical preparations • New York
DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between XOMA CORPORATION, a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
ARTICLE IConvertible Preferred Stock Purchase Agreement • August 18th, 1997 • Xoma Corp /De/ • Pharmaceutical preparations • New York
BACKGROUNDLicense Agreement • March 19th, 2004 • Xoma LTD /De/ • Pharmaceutical preparations • California
EMPLOYMENT AGREEMENT with JOHN L. CASTELLOEmployment Agreement • March 19th, 1998 • Xoma Corp /De/ • Pharmaceutical preparations • California
June 26, 1987 Mr. Ho Humphrey Xoma Corporation 2910 Seventh Street Berkeley, CA 94710 RE: BUILDING C OF AQUATIC PARK CENTER. Dear Mr. Humphrey: On or about the date of this letter, Xoma Corporation ("Xoma") and Seventh Street Properties II ("Lessor")...Right of First Refusal Agreement • March 19th, 1998 • Xoma Corp /De/ • Pharmaceutical preparations
